Clinical trial of a change-over from Torasemide to Tolvaptan for chronic heart failure after cardiac surgery

Clinical trial of a change-over from Torasemide to Tolvaptan for chronic heart failure after cardiac surgery - Clinical trial of a change-over from Torasemide to Tolvaptan for chronic heart failure after cardiac surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009402

Enrollment

Registered

2012-11-27

Start date

2012-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure after cardiac surgery

Interventions

Torvaptan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Chronic heart failure receiving Torasemide

Exclusion criteria

Exclusion criteria: Hypernatremia

Design outcomes

Primary

Measure	Time frame
NYHA class Likert Scale	—

Secondary

Measure	Time frame
1) BNP, ANP 2) Na, K, Cl 3) BUN, Cr 4) cardiac function by UCG	—

Countries

Japan

Contacts

Public ContactAkira Sezai

Nihon University School of Medicine

asezai.med@gmail.com03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026